Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06018311 · ClinicalTrials.gov registry record · NA

Hispanic Adapted and Culturally Relevant Exercising Together

A NA study of Prostate Cancer and Neoplasms, sponsored by University of Arizona.

Active
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT06018311 is a NA study of Prostate Cancer and Neoplasms that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 58 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06018311, a NA study of Prostate Cancer and Neoplasms, is active but no longer recruiting, sponsored by University of Arizona.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the feasibility and effects of an adapted Exercising Together, a partnered resistance training program, on the physical and mental health of prostate cancer survivors and their informal caregiver. The Exercising Together program is designed to promote teamwork during supervised group exercise classes delivered remotely through videoconferencing software. The intervention period will be 3-months with a 3-month follow-up.

Interventions

  • BEHAVIORAL Exercising together

Study Locations (1)

Arizona

  • University of Arizona Cancer Center - Tucson

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2023-11-01
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT06018311

The ClinicalTrials.gov registry entry for NCT06018311 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercising together is the first listed.

NCT06018311 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT06018311 about?

NCT06018311 is a clinical study titled "Hispanic Adapted and Culturally Relevant Exercising Together". The purpose of this study is to determine the feasibility and effects of an adapted Exercising Together, a partnered resistance training program, on the physical and mental health of prostate cancer survivors and their informal caregiver. The Exercising Together program is designed to promote teamwo...

What is the current status of trial NCT06018311?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2023-11-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06018311 study?

This clinical trial studies the following conditions: Prostate Cancer, Neoplasms, Exercise, Caregiver Burden, Cancer Survivors.

What interventions are being tested in trial NCT06018311?

The interventions under investigation include: Exercising together (BEHAVIORAL).

Who is sponsoring clinical trial NCT06018311?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06018311 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.